Back
Sarepta Therapeutics Vs. Trinet Group Industry Stock Comparison
Sell
50
SRPT
Sarepta Therapeutics
Last Price:
130.75
Seasonality Move:
8.89%
Sell
19
TNET
Trinet Group
Last Price:
103.86
Seasonality Move:
14.31%
Sell
50
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $132.74. The Score for SRPT is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Trinet Group (TNET)
is a Sell
Is Trinet Group a Buy, Sell or Hold?
- The current Trinet Group [TNET] share price is $103.19. The Score for TNET is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
- TNET is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $132.74
The current trend is moderately bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
TNET Stock Price Chart
What is Trinet Group's stock price today?
-
The Trinet Group share price today is $103.19
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TNET is experiencing slight selling pressure.
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.32 | Buy |
| Relative Strength Index (14 RSI): | 60.57 | Buy |
| Chaikin Money Flow: | 825203 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (120.05 - 133.59) | Buy |
| Bollinger Bands (100): | (112.21 - 133.05) | Buy |
TNET Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -6.08 | Sell |
| Relative Strength Index (14 RSI): | 32.98 | Sell |
| Chaikin Money Flow: | -68498 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (100.29 - 125.47) | Sell |
| Bollinger Bands (100): | (110.48 - 129.44) | Sell |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 132.8 | Sell |
| 20-day SMA: | 128.89 | Buy |
| 50-day SMA: | 126.17 | Buy |
| 200-day SMA: | 113.39 | Buy |
| 8-day EMA: | 132.23 | Buy |
| 20-day EMA: | 130 | Buy |
| 50-day EMA: | 126.73 | Buy |
| 200-day EMA: | 118.1 | Buy |
TNET Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 102.9 | Buy |
| 20-day SMA: | 109.08 | Sell |
| 50-day SMA: | 121.07 | Sell |
| 200-day SMA: | 116.09 | Sell |
| 8-day EMA: | 103.2 | Sell |
| 20-day EMA: | 108.45 | Sell |
| 50-day EMA: | 115.92 | Sell |
| 200-day EMA: | 113.56 | Sell |
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.06 per share, an increase next quarter of $1.31 per share, an increase this year of $6.16 per share, and an increase next year of $6.01 per share.
Trinet Group Earnings Growth & TNET Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, an increase next quarter of $0.12 per share, a decrease this year of $1.52 per share, and an increase next year of $0.83 per share.
Sarepta Therapeutics Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Trinet Group Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||